New vaccine support (NVS) for PNEUMO
GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. Pneumococcal vaccines can protect children from Streptococcus pneumoniae, which is the most common cause of severe pneumonia among children living in the developing world, and can also causes meningitis and sepsis. In line with WHO recommendations, GAVI support for pneumococcal vaccines is for routine infant immunisation. Two pneumococcal conjugate vaccines are currently available with GAVI support: a 10-valent (PCV10) and a 13-valent (PCV13).
- ID Projet
47122-1720-LBR-12C-X- Statut de l'activité
- 2 - Implementation
- Type d'aide
- B02 - Contributions aux budgets réguliers des institutions multilatérales
- % to Libéria
- 100.00
Organisations
- Funding
- The Global Alliance for Vaccination and Immunisation
- Extending
- World Health Organisation - core voluntary contributions account (for technical assitance)
- Accountable
- Federal States & Local Governments
- Implementing
- Federal States & Local Governments
- Extending
- United Nations Childrens Fund
Versements par exercice fiscal, trimestre
| Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Libéria Montant (USD) |
| 2017 |
Q3 |
1,225.00 |
1,225.00 |
| 2016 |
Q4 |
477,525.00 |
477,525.00 |
| 2016 |
Q3 |
479,525.00 |
479,525.00 |
Engagements par exercice fiscal, trimestre
| Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Libéria Montant (USD) |
| 2017 |
Q2 |
-87,725.00 |
-87,725.00 |
| 2016 |
Q1 |
1,046,000.00 |
1,046,000.00 |
Projections de CDMT par exercice fiscal
| Exercice fiscal |
Montant (USD) |
Libéria Montant (USD) |
| 2020 |
1,021,750.00 |
1,021,750.00 |
| 2019 |
1,973,500.00 |
1,973,500.00 |
| 2018 |
1,827,250.00 |
1,827,250.00 |
| 2017 |
1,398,500.00 |
1,398,500.00 |
| 2016 |
523,000.00 |
523,000.00 |
| Code CRS |
% |
|
Lutte contre les maladies infectieuses
(12250)
|
100.0
|